Search for other papers by Yuegui Wang in
Google Scholar
PubMed
Search for other papers by Liwei Hong in
Google Scholar
PubMed
School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China
Search for other papers by Caiyun Yang in
Google Scholar
PubMed
Quanzhou Medical College, Quanzhou, Fujian, China
Search for other papers by Guorong Lv in
Google Scholar
PubMed
Search for other papers by Kangjian Wang in
Google Scholar
PubMed
Search for other papers by Xuepeng Huang in
Google Scholar
PubMed
Search for other papers by Haolin Shen in
Google Scholar
PubMed
triiodothyronine, and thyrotropin receptor antibody Levels of free triiodothyronine (FT3), free thyroxine (FT4), and thyrotropin receptor antibody (TRAb) in patients' venous blood were measured using an electroluminescent immunoassay (Beckman, DXI800) after
Search for other papers by Yun Cai in
Google Scholar
PubMed
Search for other papers by Jieni Yan in
Google Scholar
PubMed
Search for other papers by Yong Gu in
Google Scholar
PubMed
Search for other papers by Heng Chen in
Google Scholar
PubMed
Search for other papers by Yang Chen in
Google Scholar
PubMed
Search for other papers by Xinyu Xu in
Google Scholar
PubMed
Search for other papers by Mei Zhang in
Google Scholar
PubMed
Search for other papers by Liping Yu in
Google Scholar
PubMed
Search for other papers by Xuqin Zheng in
Google Scholar
PubMed
Search for other papers by Tao Yang in
Google Scholar
PubMed
.2%) – <0.0001* <0.0001* <0.0001* >0.05* – – FT3 (pmol/L) 13.3 ± 11.5 4.63 ± 2.50 5.37 ± 4.28 – <0.0001 ‡ <0.0001 § <0.0001 § >0.05 § – – FT4 (pmol/L) 33.9 ± 26.0 15.3 ± 8.85 20.9 ± 14.0 – <0.0001 ‡ <0
Search for other papers by W J Bom in
Google Scholar
PubMed
Search for other papers by F B M Joosten in
Google Scholar
PubMed
Search for other papers by M M G J van Borren in
Google Scholar
PubMed
Search for other papers by E P Bom in
Google Scholar
PubMed
Search for other papers by R R J P van Eekeren in
Google Scholar
PubMed
Search for other papers by H de Boer in
Google Scholar
PubMed
–50 mm, (3) degree of cystic degeneration <50%, (4) serum TSH, FT4, and FT3 levels within the normal range, and (5) benign cytology or histology. The study was approved by the local ethical committee, and all patients gave their informed consent
2nd Department of Internal Medicine, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University in Prague, Srobarova, Prague, Czech Republic
Search for other papers by T Grimmichova in
Google Scholar
PubMed
Diabetes Centre, Institute for Clinical and Experimental Medicine (IKEM), Videnska, Prague, Czech Republic
Search for other papers by M Haluzik in
Google Scholar
PubMed
Search for other papers by K Vondra in
Google Scholar
PubMed
Search for other papers by P Matucha in
Google Scholar
PubMed
Search for other papers by M Hill in
Google Scholar
PubMed
hypo- or hyperthyroidism were re-checked for glucose disorders after reaching a euthyroid state. Basal blood samples for the determination of TSH, fT4, fT3, anti-thyroid peroxidase antibodies (anti-TPO), anti-thyroglobulin (anti-Tg), thyrotropin
Department of Pediatric Cardiology, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Xuechao Jiang in
Google Scholar
PubMed
Search for other papers by Yonghui Wang in
Google Scholar
PubMed
Search for other papers by Xiaoying Li in
Google Scholar
PubMed
Search for other papers by Leqi He in
Google Scholar
PubMed
Search for other papers by Qian Yang in
Google Scholar
PubMed
Search for other papers by Wei Wang in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
Search for other papers by Bingbing Zha in
Google Scholar
PubMed
of GD patients. Subject Age range (years) Duration of clinical manifestation (days) Hormone Autoantibody FT3 (pmol/L) FT4 (pmol/L) TSH (mIU/L) TGAb (IU/mL) TPOAb (IU/mL) TRAb (IU/L) 1 60–65 30 37
Search for other papers by M Krause in
Google Scholar
PubMed
Search for other papers by H Frederiksen in
Google Scholar
PubMed
Search for other papers by K Sundberg in
Google Scholar
PubMed
Search for other papers by F S Jørgensen in
Google Scholar
PubMed
Search for other papers by L N Jensen in
Google Scholar
PubMed
Search for other papers by P Nørgaard in
Google Scholar
PubMed
Search for other papers by C Jørgensen in
Google Scholar
PubMed
Search for other papers by P Ertberg in
Google Scholar
PubMed
Section of Biostatistics, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark
Search for other papers by J H Petersen in
Google Scholar
PubMed
Search for other papers by U Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by A Juul in
Google Scholar
PubMed
Search for other papers by K T Drzewiecki in
Google Scholar
PubMed
Search for other papers by N E Skakkebaek in
Google Scholar
PubMed
Search for other papers by A M Andersson in
Google Scholar
PubMed
exception of two samples, which were analyzed for thyroid hormones in March 2017. The thyroid hormones triiodothyronine (T 3 ), free triiodothyronine (fT 3 ), thyroxine (T 4 ) and free thyroxine (fT 4 ) were measured by competitive electrochemiluminescence
Search for other papers by Kusum Lata in
Google Scholar
PubMed
Search for other papers by Pinaki Dutta in
Google Scholar
PubMed
Search for other papers by Subbiah Sridhar in
Google Scholar
PubMed
Search for other papers by Minakshi Rohilla in
Google Scholar
PubMed
Search for other papers by Anand Srinivasan in
Google Scholar
PubMed
Search for other papers by G R V Prashad in
Google Scholar
PubMed
Search for other papers by Viral N Shah in
Google Scholar
PubMed
Search for other papers by Anil Bhansali in
Google Scholar
PubMed
vacutainers at the initial visit. Each blood sample was analysed for TSH, free tri-iodothyronine (FT 3 ), free T 4 (FT 4 ) and anti-TPO by electro-chemiluminescence immunoassay (ELECSYS-2010, Roche–Hitachi Diagnostics). The reference range for the above
Search for other papers by Qingrong Pan in
Google Scholar
PubMed
Search for other papers by Shuxin Gao in
Google Scholar
PubMed
Search for other papers by Xia Gao in
Google Scholar
PubMed
Search for other papers by Ning Yang in
Google Scholar
PubMed
Search for other papers by Zhi Yao in
Google Scholar
PubMed
Search for other papers by Yanjin Hu in
Google Scholar
PubMed
Search for other papers by Li Miao in
Google Scholar
PubMed
Search for other papers by Zhe Chen in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
normal ranges. The normal values for TSH, free triiodothyronine (FT3) and free thyroxine (FT4) were 0.55–4.78 μIU/mL, 2.3–4.2 pg/mL and 8.9–17.6 pg/mL, respectively. Exclusion criteria were as follows: patients under treatment with thyroxine, or anti
Search for other papers by Ayse Nurcan Cebeci in
Google Scholar
PubMed
Search for other papers by Vera Schempp in
Google Scholar
PubMed
Search for other papers by Katharina Förtsch in
Google Scholar
PubMed
Search for other papers by Bettina Gohlke in
Google Scholar
PubMed
Search for other papers by Michaela Marx in
Google Scholar
PubMed
Search for other papers by Helmuth-Guenther Dörr in
Google Scholar
PubMed
Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
‘block and replace’ varied between doctors in each centre. The remission of the disease was defined as the absence of symptoms of hyperthyroidism along with normalisation of laboratory measurements (fT3, fT4, and TSH concomitantly negative TSHRab) at
Search for other papers by Ru-Xuan Zhao in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Sha Luo in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Search for other papers by Jin-Kui Yang in
Google Scholar
PubMed
drug use, and history of smoking were recorded. Clinical data including serum free triiodothyronine 3 (FT3), free triiodothyronine 4 (FT4), thyroid-stimulating hormone (TSH), and thyrotropin receptor antibody (TRAb) levels were measured to assess